News 02.06.2021 Schlieren (Zurich), Switzerland, June 2, 2021 – Kuros Biosciences (SIX: KURN), a leader in next generation bone graft technologies, today provided an update on its commercial activities, with sales of MagnetOs bone graft and progress in establishing distributor networks both exceeding management expectations. Direct sales of MagnetOs in the U.S. accelerated in...
News 27.05.2021 Zurich-Schlieren, Switzerland, May 27, 2021. Molecular Partners (SIX: MOLN) and Novartis announced today the start of the clinical trial EMPATHY, a Phase 2 and 3 study, to explore the use of its novel DARPin® therapeutic candidate ensovibep (MP0420) for the treatment of COVID-19. Novartis will conduct the clinical trial program...
Events, External events
Event date: 02.06.2021
Date: 2. June 2021
Start: 08.00 am CEST
Duration: 1 hour
Together with our experts, we share some insights on how you can build safe and reliable AI for health care and share some interesting real-world use cases.
More information and registration: https://bit.ly/3xEIiqS
Events, External events
Event date: 29.06.2021
Since a full day of online training is exhausting, we divided the workshop into three days. It will be held on June, 29th, June 30th and July 1st, 2021 from 10.00 to 12.00 CEST on each of the three days.
This workshops provides you with the basics of regulatory affairs in...
Events, External events
Event date: 15.06.2021
Tuesday 15th of June at 1pm
Description
The webinar by Leva Capital Partners AG is meant to provide a comprehensive overview on how to find the right investors for your next financing round. This interactive session will cover some of the best practices to reach out and negotiate with potential investors. You...